According to WiseGuy Reports, the Empty Capsules Market was valued at USD 3.64 billion in 2024 and reached USD 3.84 billion in 2025. The market is projected to grow to USD 6.5 billion by 2035, registering a CAGR of 5.4% during the forecast period from 2026 to 2035. Rising demand for dietary supplements, expansion of the pharmaceutical industry, advancements in capsule manufacturing technology, increasing preference for vegetarian capsules, and regulatory compliance requirements are supporting market development. Major companies profiled include Roxall Pharmaceuticals, Qualicaps, MediGel, Hermann Burchardt, Softgel Technologies, Baihe Biotech, Crown Capsules, Lonza, Capsugel, ACG Capsules, ShenZhen JinYuan Capsules, Dawson Holdings, Medipharma, Famar Health Care Services, Ginkgo BioWorks, and Suheung Co.

Market Overview

The Empty Capsules Market is an important component of the pharmaceutical and nutraceutical manufacturing supply chain. Empty capsules are used as delivery shells for active pharmaceutical ingredients, dietary supplements, and selected cosmetic and food applications. Their ability to accommodate different formulations and dosage requirements supports demand from manufacturers seeking practical solutions for product development and production.

The market includes gelatin capsules, vegetable capsules, and enteric-coated capsules. These products serve different formulation and delivery requirements, while immediate-release, sustained-release, and controlled-release functionalities address varying dosage needs. Capsule sizes, including small, medium, and large formats, allow manufacturers to select products according to fill volume and application specifications.

Pharmaceutical companies, nutraceutical manufacturers, cosmetics producers, and food industry participants represent key end-use segments. Demand patterns vary according to product development, manufacturing capabilities, consumer preferences, and applicable regulatory standards.

Market Size Reached in 2025

The Empty Capsules Market reached USD 3.84 billion in 2025, compared with USD 3.64 billion in 2024. This market value reflects the continuing use of capsule-based delivery formats in pharmaceutical and dietary supplement production. Manufacturers require empty capsules that meet relevant quality, compatibility, and performance specifications.

Gelatin capsules remain an established category in the industry, while vegetable capsules serve manufacturers seeking non-animal-based alternatives. The selection between capsule types depends on formulation requirements, consumer preferences, production processes, and product positioning.

The demand for empty capsules is also influenced by developments in pharmaceutical formulations and nutraceutical products. Manufacturers are evaluating capsule solutions that support efficient filling, reliable performance, and consistency across production batches.

Key Growth Drivers

The growing pharmaceutical industry is a significant factor supporting demand for empty capsules. Pharmaceutical manufacturers use capsule formats for various drug formulations, creating ongoing requirements for suitable capsule shells. Expansion in pharmaceutical production and product development can contribute to demand across different capsule sizes and functionalities.

Rising demand for dietary supplements is another important market driver. Consumers are increasingly purchasing products designed to support nutritional and wellness objectives, contributing to opportunities in the nutraceutical sector. Capsule-based supplements offer manufacturers a format that can accommodate different ingredients and formulation approaches.

The increasing preference for vegetarian capsules is also influencing product development. Vegetable-based capsule options can serve consumers and brands seeking alternatives to gelatin-based products. Adoption depends on product formulation, consumer demand, manufacturing considerations, and the availability of suitable raw materials.

Regulatory compliance and quality standards remain essential to the industry. Capsule manufacturers must address relevant requirements concerning material quality, production processes, and suitability for intended applications. Consistent quality and reliable manufacturing capabilities are important considerations for pharmaceutical and nutraceutical customers.

Expected Market Size by 2035

The Empty Capsules Market is projected to reach USD 6.5 billion by 2035. The expected expansion is supported by pharmaceutical industry growth, increasing dietary supplement consumption, and continued innovation in capsule manufacturing technologies.

Personalized medicine represents an area of potential opportunity. The development of therapies tailored to specific patient requirements may create demand for dosage forms and delivery solutions adapted to particular formulations. The extent of demand for empty capsules will depend on the types of therapies developed and the manufacturing processes used.

Vegetarian capsule adoption may also contribute to future market development. As manufacturers respond to changing dietary preferences and product positioning, alternative capsule materials may receive greater attention. Product performance, stability, cost, and formulation compatibility will influence their suitability across applications.

Market CAGR

The market is expected to grow at a CAGR of 5.4% between 2026 and 2035. This projected growth reflects continued demand for capsule-based delivery systems across pharmaceutical, nutraceutical, and other end-use industries.

Advancements in capsule manufacturing technology may support improvements in production efficiency, product consistency, and specialized functionality. Manufacturers are exploring solutions that address specific formulation requirements, including release characteristics and compatibility with different active ingredients.

The pace of market expansion will be influenced by pharmaceutical production volumes, supplement demand, regulatory developments, and investments in manufacturing infrastructure across regional markets.

Emerging Market Trends

Vegetarian and plant-based capsule solutions are gaining attention as manufacturers respond to consumer preferences and product differentiation strategies. These capsules can provide alternatives to traditional gelatin formats in suitable applications. Their adoption depends on formulation requirements, production performance, and market-specific consumer expectations.

Capsule functionality is another area of innovation. Immediate-release capsules are designed for formulations requiring prompt release, while sustained-release and controlled-release approaches address different delivery objectives. The selection of capsule technology depends on the intended product design and relevant formulation requirements.

Advancements in manufacturing technology are also shaping the industry. Improvements in capsule production and filling compatibility may support more consistent output and specialized product development. Manufacturers are examining ways to meet customer requirements related to capsule quality, performance, and production efficiency.

The expansion of nutraceutical applications presents additional opportunities. Dietary supplements and wellness products are available in various formulations, and capsule-based delivery can serve selected ingredient combinations and consumer preferences.

Competitive Landscape

The Empty Capsules Market includes manufacturers and suppliers specializing in pharmaceutical-grade capsule shells, nutraceutical applications, and related production technologies. Roxall Pharmaceuticals, Qualicaps, MediGel, Hermann Burchardt, Softgel Technologies, Baihe Biotech, Crown Capsules, Lonza, Capsugel, ACG Capsules, ShenZhen JinYuan Capsules, Dawson Holdings, Medipharma, Famar Health Care Services, Ginkgo BioWorks, and Suheung Co are among the companies profiled in the market assessment.

Competition is influenced by product quality, manufacturing capabilities, capsule material options, functional innovation, and regulatory compliance. Companies may pursue growth through expanded production capacity, vegetarian capsule development, and solutions designed for pharmaceutical and nutraceutical manufacturers.

The projected expansion of the Empty Capsules Market through 2035 reflects the continuing importance of capsule-based delivery formats. As pharmaceutical companies and supplement manufacturers develop new products, opportunities in capsule functionality, alternative materials, manufacturing technology, and specialized applications are expected to influence the industry's future direction.